Toragen, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Trial in Patients With Human Papillomavirus (HPV)-Associated Cancer (NCT05826275) | Toragen, Inc. | 2023-06-20 |
Track Toragen, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.